Agilon Health (NYSE:AGL) Trading 3.3% Higher – Here’s Why

Agilon Health, Inc. (NYSE:AGL)’s stock price was up 3.3% during mid-day trading on Thursday . The stock traded as high as $97.26 and last traded at $96.6460. 26,568 shares traded hands during mid-day trading, a decline of 92% from the average session volume of 341,372 shares. The stock had previously closed at $93.59.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on AGL shares. Robert W. Baird set a $116.00 price target on Agilon Health in a research report on Thursday, August 6th. JPMorgan Chase & Co. increased their price objective on Agilon Health from $31.00 to $85.00 and gave the stock an “underweight” rating in a report on Monday, August 24th. Truist Financial set a $112.00 price objective on Agilon Health and gave the company a “hold” rating in a research report on Thursday, August 6th. Wells Fargo & Company reaffirmed an “overweight” rating and issued a $146.00 target price (up from $141.00) on shares of Agilon Health in a research report on Tuesday, August 11th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Agilon Health in a research note on Monday, August 24th. Five equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, Agilon Health currently has an average rating of “Hold” and an average target price of $97.70.

Agilon Health Trading Up 0.6%

The stock has a 50-day moving average of $100.55 and a two-hundred day moving average of $68.36. The company has a market cap of $1.58 billion, a P/E ratio of -6.59 and a beta of 3.02. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.08 and a current ratio of 1.08.

Agilon Health (NYSE:AGL) last released its earnings results on Wednesday, August 5th. The company reported $1.04 EPS for the quarter, topping analysts’ consensus estimates of $0.14 by $0.90. Agilon Health had a negative return on equity of 119.38% and a negative net margin of 3.92%.The firm had revenue of $1.49 billion for the quarter, compared to analysts’ expectations of $1.45 billion. On average, equities research analysts predict that Agilon Health, Inc. will post -2.11 earnings per share for the current year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of AGL. AQR Capital Management LLC lifted its stake in shares of Agilon Health by 243.3% in the first quarter. AQR Capital Management LLC now owns 501,440 shares of the company’s stock worth $2,171,000 after buying an additional 355,365 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Agilon Health by 3.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 214,200 shares of the company’s stock worth $927,000 after acquiring an additional 7,209 shares during the last quarter. Dynamic Technology Lab Private Ltd lifted its position in Agilon Health by 28.4% in the 1st quarter. Dynamic Technology Lab Private Ltd now owns 47,111 shares of the company’s stock valued at $204,000 after acquiring an additional 10,424 shares in the last quarter. Goldman Sachs Group Inc. lifted its position in Agilon Health by 6.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 5,060,333 shares of the company’s stock valued at $21,911,000 after acquiring an additional 311,158 shares in the last quarter. Finally, Creative Planning boosted its stake in Agilon Health by 17.6% during the 2nd quarter. Creative Planning now owns 170,969 shares of the company’s stock valued at $393,000 after purchasing an additional 25,548 shares during the last quarter.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.